We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Bristol-Myers Squibb Pharmaceuticals Limited has informed the MHRA that a potential product quality issue has been detected, relating to incomplete crimping of the metal crimp cap of OPDIVO 10mg/mL concentrate for solution for infusion (nivolumab) (1VLX10ML).
Novartis Pharmaceuticals UK Limited is recalling Adakveo 10 mg/ml concentrate for solution for infusion due to the benefit-risk balance of Adakveo no longer being considered favourable by the MHRA.
Change to the information provided on adverse events in the Summary of Product Characteristics (SPC).
Statement by UK Political Coordinator Fergus Eckersley at the UN Security Council meeting on Kosovo.
A. Menarini Farmaceutica Internazionale Srl is recalling a specific batch as a precautionary measure due to the distribution of Invokana 300mg in Northern Ireland in packaging intended for the Greek market.
Accord Healthcare Ltd, UK has informed the MHRA about an error with the Patient Information Leaflets (PILs) that have been packaged in the batches of these products mentioned in this notification.
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
How bottled water producers can get a natural mineral water recognised in England, and rules you need to follow to produce and label it.
Product defect recall alert for NARKETAN-10 100mg/ml Solution for Injection, Vm 08007/4090 by Vetoquinol UK Ltd.
Product defect recall alert for Anesketin 100 mg/ml 5ml Solution for Injection for Dogs, Cats and Horses due to a discrepancy in processing settings.
Batches of Legency Remedies Pvt Ltd irrigation, inhalation and eye wash saline products manufactured between April and November 2023 are being recalled due to potential microbiological contamination.
Find out what animal by-products you can use to make biodiesel, whether you need approval, how to process them and how to use the products.
Hikma Farmacêutica Portugal S.A has informed the MHRA of a potential issue impacting the batches listed in this notification.
Sanofi UK is recalling the listed batches of Sabril tablets and Sabril granules as a precautionary measure due to the detection of traces of tiapride in the batches of the source material of manufacturer for vigabatrin.
Novartis Pharmaceuticals has informed the MHRA that the solvent (water for injections in ampoules) co-packed with the impacted batches of Simulect powder for injection, may contain glass fragments approximately 20 – 800 µm in size.
Volume 42 of the non-technical summaries granted under the Animals (Scientific Procedures) Act 1986 during 2013.
Advice and guidance on the health needs of migrant patients from Solomon Islands for healthcare practitioners.
Check the tariff classification for oilcake and other residues resulting from the extraction of olive oil.
Volume 40 of the non-technical summaries granted under the Animals (Scientific Procedures) Act 1986 during 2013.
Volume 52 of the non-technical summaries granted under the Animals (Scientific Procedures) Act 1986 during 2013.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.